Critical Care Devices Market size surpassed USD 55 Billion in 2023 and is poised to reach USD 90 Billion by end of the year 2032, growing at over 5% CAGR between 2024 and 2032.
Growth Drivers:
1. Technological Advancements: The critical care devices market is being driven by ongoing technological advancements, such as the development of sophisticated monitoring systems, advanced ventilators, and improved patient management software. These technological advancements are helping healthcare providers to deliver more efficient and accurate critical care, ultimately driving demand for critical care devices.
2. Increasing Prevalence of Chronic Diseases: The rising prevalence of chronic diseases, such as cardiovascular diseases, respiratory diseases, and neurological disorders, is driving the demand for critical care devices. As the global population continues to age and the incidence of chronic diseases increases, the need for critical care services and devices is expected to grow significantly.
3. Growing Demand for Home Healthcare: There is a growing trend towards home healthcare and remote monitoring, driven by the increasing preference for personalized care and the rising healthcare costs. This trend is leading to the increased adoption of critical care devices for home use, such as portable ventilators, oxygen therapy devices, and tele-ICU monitoring systems.
4. Increasing Investments in Healthcare Infrastructure: The rising investments in healthcare infrastructure, especially in emerging markets, are driving the growth of the critical care devices market. These investments are aimed at expanding and upgrading the healthcare facilities, increasing the accessibility of critical care services, and improving the overall quality of care, which in turn is boosting the demand for critical care devices.
Report Coverage | Details |
---|---|
Segments Covered | Product, Application Field, End-use |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Koninklijke Philips N.V., ResMed, Drägerwerk AG & Co. KGaA, GE Healthcare, Medtronic Plc., ICU Medical, Inc., Fresenius Medical Care, Smiths Medical, Biometrix, Airon Corporation, OSI Systems, Avanos Medical, Skanray Technologies Pvt. Ltd, Becton Dickinson and Company (BD), Boston Scientific corporation, Getinge AB, Hamilton Medical, VYAIRE, Q-core Medical, Ventec Life Systems, Bunnell Incorporated, Teleflex Incorporated, Asahi Kasei Corporation, Air Liquide Medical Systems India, Breas Medical, Cardinal Health, Baxter, B. Braun Melsungen AG |
1. High Cost of Critical Care Devices: The high initial cost of critical care devices, including ventilators, cardiac monitors, and infusion pumps, is a major industry restraint. The substantial investment required for purchasing and maintaining these devices can be a barrier for healthcare facilities, particularly in low- and middle-income countries, limiting the widespread adoption of critical care devices.
2. Stringent Regulatory Requirements: The critical care devices market is hindered by stringent regulatory requirements, particularly in terms of product approvals and compliance with quality and safety standards. These regulations can significantly delay the introduction of new products to the market, increasing the time and cost of development for manufacturers and potentially limiting the availability of innovative critical care devices for patients and healthcare providers.
The critical care devices market in North America, particularly in the U.S., is expected to witness significant growth due to the increasing prevalence of chronic diseases and a rising geriatric population. The presence of well-established healthcare infrastructure and favorable reimbursement policies are further driving market growth in the region.
In the Asia Pacific region, countries such as China, Japan, and South Korea are expected to experience substantial growth in the critical care devices market. This can be attributed to the increasing investments in healthcare infrastructure, growing healthcare expenditure, and a rising awareness about critical care management. Additionally, the presence of a large patient population and ongoing advancements in healthcare technology are contributing to the growth of the market in these countries.
In Europe, particularly in the United Kingdom, Germany, and France, the critical care devices market is projected to witness steady growth. This can be attributed to the increasing healthcare expenditure, the presence of sophisticated healthcare systems, and a growing emphasis on advanced critical care management. Additionally, the rising prevalence of chronic diseases, coupled with a growing aging population, is expected to drive market growth in these countries.
Overall, the critical care devices market is expected to experience significant growth in North America, Asia Pacific, and Europe, driven by factors such as increasing healthcare expenditure, rising prevalence of chronic diseases, and ongoing advancements in healthcare technology.
The critical care devices market can be segmented by product, application field, and end-use. One subsegment of the product segment is the ventilators. Ventilators play a crucial role in critical care settings as they help patients who are unable to breathe on their own. These devices are used in various medical conditions such as acute respiratory distress syndrome (ARDS), pneumonia, and other respiratory disorders. With the increasing prevalence of respiratory diseases and the ongoing COVID-19 pandemic, the demand for ventilators in critical care settings is expected to grow significantly.
In terms of application field, one subsegment is the cardiology. Critical care devices used in cardiology include cardiac monitors, defibrillators, and intra-aortic balloon pumps, among others. These devices are essential for monitoring and treating patients with heart-related emergencies such as heart attacks, arrhythmias, and heart failure. With the rising burden of cardiovascular diseases globally, the demand for critical care devices in the cardiology field is expected to continue to expand.
As for the end-use segment, one subsegment is hospitals. Hospitals are the largest end-users of critical care devices, as they are the primary settings for providing critical care to patients. These facilities require a wide range of critical care devices such as patient monitors, infusion pumps, and anesthesia machines to support the treatment of patients in intensive care units (ICUs), emergency departments, and operating rooms. With the growing number of hospital admissions and surgical procedures, the demand for critical care devices in hospitals is expected to remain high.
The critical care devices market is highly competitive, with a number of key players dominating the industry. Major players in this market are constantly focusing on improving their product offerings to stay ahead of the competition. The market is characterized by intense rivalry, rapid technological advancements, and the need for substantial investments in research and development. The key players in the critical care devices market are continually striving to expand their global presence through strategic partnerships, mergers, acquisitions, and collaborations.
Top Market Players:
1. Medtronic
2. General Electric Company
3. Koninklijke Philips N.V.
4. Becton, Dickinson and Company
5. Smiths Group plc
6. Fresenius SE & Co. KGaA
7. Drägerwerk AG & Co. KGaA
8. Getinge AB
9. Hamilton Medical
10. Nihon Kohden Corporation
Recent Industry Developments:
1. In July 2021, Medtronic announced the acquisition of privately-held Intersect ENT, Inc., a company that provides sinus implants and related medical devices for the treatment of patients with ear, nose, and throat conditions.
2. In May 2021, General Electric Company launched a new version of its CARESCAPE R860 Ventilator, which provides a simplified user experience, advanced tools, and analytics to help clinicians manage patient ventilation.
3. In April 2021, Philips announced a partnership with Masimo Corporation to integrate Masimo's measurement technologies into select Philips patient monitoring devices, providing clinicians with advanced patient monitoring and therapy solutions.